FBXL7 and glioma: In several cancers, much focus has been paid on the examining molecular biomarkers carrying vital information in glioma prevention, diagnosis and prognosis, as well as treatment.37 Knock‐down of a commonly reported oncogenic factor, FBXL7 impeded in vitro migration and invasion, as well as the epithelial‐mesenchymal transition in gastric cancer cells and stalled metastasis of gastric cancer cells in vivo, reduced invasive abilities and initiated cell apoptosis and cell cycle arrest in tongue squamous cell cancer.35